Company intelligence / Profile preview

Fluidx Medical Technology

Salt Lake City, Utah, United Statesfluidxmedical.com ↗

Ownership: Private
Development stage: Clinical

Overview

The GPX Embolic Device completed a successful multi-center clinical trial in which it achieved high technical success and usability scores. It demonstrated complete vessel occlusion and ease of use. A pivotal multinational clinical trial began in late 2024 after FDA IDE approval. Results from the earlier multicenter study were published in JVIR. All products are investigational and not yet approved or cleared for marketing.

Therapeutic areas: OncologyHematologyGastroenterologyCardiovascularWomen's Health
Modalities: DeviceNanoparticleBiologic
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

GPX Embolic Device

Clinical

Indications: cancer, hypervascular tumors, vessel malformations, internal bleeds

2 more assets in the full pipeline.

Request access →

Partnerships

Large multinational strategic investor participated in Series A round

Beyond the preview

Go deeper on Fluidx Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluidx Medical Technology.

Explore the full profile